RheumaGen has filed a notice of an exempt offering of securities to raise $15 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RheumaGen is raising up to $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Legal Officer, Ryan Hart played a key…